Peter Carmeliet

{{Short description|Belgian physician and professor}}

{{Use dmy dates|date=November 2021}}

{{Infobox scientist

|name = Peter Carmeliet

|image =

|birth_date = {{birth-date and age|8 December 1959}}

|birth_place =

|nationality = Belgian

|field = angiogenesis

|work_institutions = KU Leuven
VIB

|alma_mater = KU Leuven

|doctoral_advisor =

|doctoral_students = Diether Lambrechts

|known_for =

|influences =

|prizes = Ernst Jung Prize
Heineken Prize for Medicine

|influenced =

}}

Peter, Baron Carmeliet ({{IPA|nl|ˈpeːtər ˈkɑrməlit|lang}}; born 8 December 1959){{cite web|url=https://www.knaw.nl/nl/actueel/nieuws/knaw-kiest-26-nieuwe-leden-2017 |title=KNAW kiest 26 nieuwe leden |language=nl |publisher=Royal Netherlands Academy of Arts and Sciences |date=10 May 2017 |access-date=14 May 2017}} is a Belgian physician and professor at the Katholieke Universiteit Leuven (Leuven, Belgium). He is also Adjunct Director of the VIB Vesalius Research Center, KU Leuven. Among his research interests are vasculogenesis, angiogenesis, and vascular endothelial growth factor (VEGF).{{cite journal | last1=Carmeliet | first1=Peter | last2=Ferreira | first2=Valérie | last3=Breier | first3=Georg | last4=Pollefeyt | first4=Saskia | last5=Kieckens | first5=Lena | last6=Gertsenstein | first6=Marina | last7=Fahrig | first7=Michaela | last8=Vandenhoeck | first8=Ann | last9=Harpal | first9=Kendraprasad | last10=Eberhardt | first10=Carmen | last11=Declercq | first11=Cathérine | last12=Pawling | first12=Judy | last13=Moons | first13=Lieve | last14=Collen | first14=Désiré | last15=Risau | first15=Werner | last16=Nagy | first16=Andras | title=Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | journal=Nature | publisher=Springer Science and Business Media LLC | volume=380 | issue=6573 | year=1996 | issn=0028-0836 | doi=10.1038/380435a0 | pages=435–439| pmid=8602241 | bibcode=1996Natur.380..435C | s2cid=4363931 }}{{cite journal | last1=Ferrara | first1=Napoleone | last2=Carver-Moore | first2=Karen | last3=Chen | first3=Helen | last4=Dowd | first4=Mary | last5=Lu | first5=Lucy | last6=O'Shea | first6=K. Sue | last7=Powell-Braxton | first7=Lyn | last8=Hillan | first8=Kenneth J. | last9=Moore | first9=Mark W. | title=Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | journal=Nature | publisher=Springer Science and Business Media LLC | volume=380 | issue=6573 | year=1996 | issn=0028-0836 | doi=10.1038/380439a0 | pages=439–442| pmid=8602242 | bibcode=1996Natur.380..439F | hdl=2027.42/62597 | s2cid=4317504 | hdl-access=free }}{{cite journal | last1=Fischer | first1=Christian | last2=Jonckx | first2=Bart | last3=Mazzone | first3=Massimiliano | last4=Zacchigna | first4=Serena | last5=Loges | first5=Sonja | last6=Pattarini | first6=Lucia | last7=Chorianopoulos | first7=Emmanuel | last8=Liesenborghs | first8=Laurens | last9=Koch | first9=Marta | last10=De Mol | first10=Maria | last11=Autiero | first11=Monica | last12=Wyns | first12=Sabine | last13=Plaisance | first13=Stephane | last14=Moons | first14=Lieve | last15=van Rooijen | first15=Nico | last16=Giacca | first16=Mauro | last17=Stassen | first17=Jean-Marie | last18=Dewerchin | first18=Mieke | last19=Collen | first19=Desire | last20=Carmeliet | first20=Peter | title=Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels | journal=Cell | publisher=Elsevier BV | volume=131 | issue=3 | year=2007 | issn=0092-8674 | doi=10.1016/j.cell.2007.08.038 | pages=463–475| pmid=17981115 | s2cid=1071689 | doi-access=free }} In 2016, Carmeliet identified neuron-producing stem cells in the brain.{{cite web | title=Scientists discover neuron-producing stem cells in the membranes covering the brain: Possible implications for brain regeneration? – ScienceDaily | website=ScienceDaily | date=26 November 2021 | url=https://www.sciencedaily.com/releases/2016/11/161123124137.htm | access-date=27 November 2021}}

Carmeliet was elected a foreign member of the Royal Netherlands Academy of Arts and Sciences in 2017.{{cite web|url=https://www.knaw.nl/en/members/foreign-members/15424 |archive-url=https://web.archive.org/web/20170514074046/https://www.knaw.nl/en/members/foreign-members/15424 |title=Peter Carmeliet |publisher=Royal Netherlands Academy of Arts and Sciences |archive-date=14 May 2017}} By the number of citations, he is the most cited author of Nature Medicine.{{Cite web |url=https://exaly.com/author/1418557/peter-carmeliet/rankings |title=Peter Carmeliet citation rankings |website=Exaly | access-date=2022-06-03}}

Awards

  • 2002: Francqui Prize on Biological and Medical Sciences.{{cite web | title=Crick Lecture: Peter Carmeliet | website=Crick | url=https://www.crick.ac.uk/whats-on/crick-lecture-peter-carmeliet | access-date=27 November 2021}}
  • 2005: Interbrew-Baillet Latour Health Prize, together with Désiré Collen.Bloom S., Belgian scientists awarded top honors, J Clin Invest. 2005 May;115(5):1106-7
  • 2010: Ernst Jung Prize in Medicine.{{Cite web|url=http://www.kuleuven.be/ci/28/ci28_carmeliet.html|title=Campus Insight – K.U.Leuven}}
  • 2018: Heineken Prize for Medicine{{cite web|url=https://www.knaw.nl/en/awards/heineken-prizes/peter-carmeliet |archive-url=https://web.archive.org/web/20190527120502/https://www.knaw.nl/en/awards/heineken-prizes/peter-carmeliet |title=Peter Carmeliet |publisher=Royal Netherlands Academy of Arts and Sciences |archive-date=27 May 2019 |url-status=live}}

References